Trial Profile
A trial to study the effect of fingolimod for the treatment of multiple sclerosis in patients younger than age 18 years
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 May 2016
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 10 May 2016 New trial record